Oxurion NV
XBRU:OXUR

Watchlist Manager
Oxurion NV Logo
Oxurion NV
XBRU:OXUR
Watchlist
Price: 0.24 EUR -4% Market Closed
Market Cap: 616.8k EUR
Have any thoughts about
Oxurion NV?
Write Note

P/OCF
Price to OCF

-0.1
Current
-4.5
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-0.1
=
Market Cap
616.8k EUR
/
Operating Cash Flow
-4.6m EUR
All Countries
Close
Market Cap P/OCF
BE
Oxurion NV
XBRU:OXUR
616.8k EUR -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -241 884.9
US
Abbvie Inc
NYSE:ABBV
320.5B USD 19.4
US
Amgen Inc
NASDAQ:AMGN
140.8B USD 19.3
US
Gilead Sciences Inc
NASDAQ:GILD
114.4B USD 11.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.4B USD -124.5
US
Epizyme Inc
F:EPE
94.1B EUR -465.1
AU
CSL Ltd
ASX:CSL
137B AUD 30.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.4B USD 18.6
US
Seagen Inc
F:SGT
39.3B EUR -75.1
NL
argenx SE
XBRU:ARGX
36.5B EUR -145.5
 
BE
Oxurion NV
XBRU:OXUR
Average P/OCF: 19.9
Negative Multiple: -0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -241 884.9
US
Abbvie Inc
NYSE:ABBV
19.4
US
Amgen Inc
NASDAQ:AMGN
19.3
US
Gilead Sciences Inc
NASDAQ:GILD
11.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -465.1
AU
CSL Ltd
ASX:CSL
30.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -145.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A